131 related articles for article (PubMed ID: 37589510)
1. Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study.
Gong EJ; Jung HK; Lee B; Hong J; Kim JW; Shin CM; Youn YH; Lee KJ
Aliment Pharmacol Ther; 2023 Oct; 58(7):668-677. PubMed ID: 37589510
[TBL] [Abstract][Full Text] [Related]
2. Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study.
Kim HJ; Kim YJ; Seo SI; Shin WG; Park CH
Gastrointest Endosc; 2020 Sep; 92(3):613-622.e1. PubMed ID: 32473251
[TBL] [Abstract][Full Text] [Related]
3. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
4. Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer: A Systematic Review and Meta-Analysis.
Zhao B; Zhang J; Mei D; Luo R; Lu H; Xu H; Huang B
J Clin Gastroenterol; 2020 Mar; 54(3):235-241. PubMed ID: 30829904
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
6. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.
Mori G; Nakajima T; Asada K; Shimazu T; Yamamichi N; Maekita T; Yokoi C; Fujishiro M; Gotoda T; Ichinose M; Ushijima T; Oda I
Gastric Cancer; 2016 Jul; 19(3):911-8. PubMed ID: 26420267
[TBL] [Abstract][Full Text] [Related]
7. Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.
Bae SE; Jung HY; Kang J; Park YS; Baek S; Jung JH; Choi JY; Kim MY; Ahn JY; Choi KS; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Am J Gastroenterol; 2014 Jan; 109(1):60-7. PubMed ID: 24343545
[TBL] [Abstract][Full Text] [Related]
8. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Kim YI; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Ryu KW; Kim YW
Helicobacter; 2014 Jun; 19(3):194-201. PubMed ID: 24612125
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
Shin SH; Jung DH; Kim JH; Chung HS; Park JC; Shin SK; Lee SK; Lee YC
PLoS One; 2015; 10(11):e0143257. PubMed ID: 26580072
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma.
Choi J; Kim SG; Yoon H; Im JP; Kim JS; Kim WH; Jung HC
Clin Gastroenterol Hepatol; 2014 May; 12(5):793-800.e1. PubMed ID: 24100112
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori Treatment and Gastric Cancer Risk After Endoscopic Resection of Dysplasia: A Nationwide Cohort Study.
Yoo HW; Hong SJ; Kim SH
Gastroenterology; 2024 Feb; 166(2):313-322.e3. PubMed ID: 37863270
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
Oura H; Matsumura T; Kawasaki Y; Okimoto K; Ishikawa K; Kaneko T; Tokunaga M; Oike T; Imai Y; Yokoyama Y; Akizue N; Maruoka D; Ohta Y; Saito K; Nakagawa T; Arai M; Kato J; Kato N
Scand J Gastroenterol; 2020 Feb; 55(2):209-215. PubMed ID: 32008404
[No Abstract] [Full Text] [Related]
15. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH
N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
17. The Effect of
Song JH; Yang SY; Lim JH; Choi JM; Kim SG
Korean J Gastroenterol; 2017 Jul; 70(1):27-32. PubMed ID: 28728313
[TBL] [Abstract][Full Text] [Related]
18. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Fukase K; Kato M; Kikuchi S; Inoue K; Uemura N; Okamoto S; Terao S; Amagai K; Hayashi S; Asaka M;
Lancet; 2008 Aug; 372(9636):392-7. PubMed ID: 18675689
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Metachronous Gastric Cancer Development After Endoscopic Submucosal Dissection for Early Gastric Cancer.
Ami R; Hatta W; Iijima K; Koike T; Ohkata H; Kondo Y; Ara N; Asanuma K; Asano N; Imatani A; Shimosegawa T
J Clin Gastroenterol; 2017 Jul; 51(6):494-499. PubMed ID: 27505404
[TBL] [Abstract][Full Text] [Related]
20. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
